Skip to main content

Table 2 Quality assessment analysis

From: Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials

RCT Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessors Incomplete outcome data Selective reporting  
Chen et al. [22] U U U U L L Poor
Chullikana et al. [21] L L L L L L Good
Gao et al. [15] L L L L H L Fair
Gao et al. [16] L L H L L L Fair
Hare et al. [23] L L L L H L Fair
Lee et al. [19] U U H L H L Poor
Wang et al. [17] U U U L L L Poor
Kharlamov et al. [24] U U U U L L Poor
Houtgraaf et al. [13] L L L L L L Good
Rodrigo et al. [18] H U U U L L Poor
Penn et al. [20] U U L L L L Fair
Kim et al. [25] L U L L L L Good
Zhang et al. [26] L U L U L L Fair
  1. H: high risk, U: unclear risk, L: low risk (Cochrane Handbook For Systematic Reviews Of Intervention)